ZD6474 enhances paclitaxel antiprolifera
β
Siddik Sarkar; Abhijit Mazumdar; Rupesh Dash; Devanand Sarkar; Paul B. Fisher; M
π
Article
π
2010
π
John Wiley and Sons
π
English
β 624 KB
## Abstract Chemotherapy employing paclitaxel and docetaxel is widely used for treating earlyβstage breast cancer and metastasis, which is frequently associated with overexpression of epidermal growth factor receptor (EGFR) and resistance to apoptosis. ZD6474, a dual tyrosine kinase inhibitor of EG